SOLB.BR

Solvay SA [SOLB.BR] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

SOLB.BR Stock Summary

Earnings have grown 40.54% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

SOLB.BR's dividend payments are well covered by cash flows with cash payout ratio of 21.16%.

SOLB.BR has more than 103 years of cash runway (1243 months)

Earnings are expected to fall -31.09% next year

EPS has been decreasing for the past 3 quarters (Quarter statements)

Top 10 Correlated ETFs

SOLB.BR

Top 10 Correlated Stocks

SOLB.BR

In the News

SOLB.BR Financial details

Company Rating

Buy

Market Cap

10.28B

Income

1.91B

Revenue

16.07B

Book val./share

102.19

Cash/share

10.97

Dividend

3.89

Dividend %

3.92%

Employees

21K

Optionable

Shortable

Yes

Earnings

04 May 2023

P/E

5.4

Forward P/E

10.99

PEG

0.54

P/S

0.64

P/B

0.97

P/C

8.99

P/FCF

9.37

Quick Ratio

0.23

Current Ratio

1.44

Debt / Equity

0.94

LT Debt / Equity

0.23

EPS (TTM)

18.36

EPS next Y

8.97

EPS next Q

EPS this Y

100.77%

EPS next Y

-51.13%

EPS next 5Y

-51.13%

EPS last 5Y

17.19%

Revenue last 5Y

7.3%

Revenue Q/Q

-11.41%

EPS Q/Q

-8.53%

SMA20

-9.4%

SMA50

-3.64%

SMA100

7.78%

Inst Own

Inst Trans

ROA

ROE

18%

ROC

0.15%

Gross Margin

25%

Oper. Margin

15%

Profit Margin

12%

Payout

21%

Shs Outstand

103.64M

Shs Float

68.7M

Target Price

52W Range

74.04-112.95

52W High

-11.95%

52W Low

+33.27%

RSI

37.94

Rel Volume

0.85

Avg Volume

210.11K

Volume

178.02K

Perf Week

2.6%

Perf Month

-9.11%

Perf Quarter

15.56%

Perf Half Y

21.63%

Beta

1.31876

Volatility

1.49%, 4.61%

Prev Close

-1.14%

Price

98.62

Change

-1.72%

SOLB.BR Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	109.4	108.71	94.18	110.45	154.91
Net income per share	8.31	1.14	-9.33	9.16	18.36
Operating cash flow per share	16.65	17.57	12.04	14.48	19.34
Free cash flow per share	8.59	9.28	6.85	8.34	10.57
Cash per share	13.11	10.33	11.82	11.3	10.97
Book value per share	101.76	92.12	69.78	84.41	102.2
Tangible book value per share	25.1	24.33	18.4	32.54	49.58
Share holders equity per share	101.76	92.12	69.78	84.41	102.2
Interest debt per share	38.77	46.16	35.88	33.38	29.67
Market cap	9.02B	10.67B	9.99B	10.58B	9.8B
Enterprise value	11.71B	14.37B	12.5B	12.99B	11.83B
P/E ratio	10.51	90.41	-10.39	11.16	5.14
Price to sales ratio	0.8	0.95	1.03	0.93	0.61
POCF ratio	5.24	5.88	8.05	7.06	4.89
PFCF ratio	10.17	11.14	14.13	12.26	8.93
P/B Ratio	0.86	1.12	1.39	1.21	0.92
PTB ratio	0.86	1.12	1.39	1.21	0.92
EV to sales	1.04	1.28	1.29	1.14	0.74
Enterprise value over EBITDA	5.56	9.19	25.36	6.45	3.74
EV to operating cash flow	6.81	7.91	10.06	8.66	5.9
EV to free cash flow	13.2	15	17.68	15.05	10.78
Earnings yield	0.1	0.01	-0.1	0.09	0.19
Free cash flow yield	0.1	0.09	0.07	0.08	0.11
Debt to equity	1.08	1.23	1.32	1.28	0.94
Debt to assets	0.52	0.55	0.57	0.56	0.48
Net debt to EBITDA	1.28	2.36	5.09	1.2	0.64
Current ratio	1.68	1.53	1.62	1.24	1.44
Interest coverage	5.59	4.55	4.42	12.05	20.66
Income quality	2	15.38	-1.29	1.58	1.04
Dividend Yield	0.05	0.04	0.04	0.04	0.04
Payout ratio	0.48	3.61	-0.44	0.41	0.21
Sales general and administrative to revenue	0.09	0.08	0.09	0.08	0.07
Research and developement to revenue	0.03	0.03	0.03	0.03	0.02
Intangibles to total assets	0.37	0.33	0.32	0.27	0.27
Capex to operating cash flow	-0.48	-0.47	-0.43	-0.42	-0.45
Capex to revenue	-0.07	-0.08	-0.06	-0.06	-0.06
Capex to depreciation	-0.88	-0.83	-0.53	-0.75	-0.98
Stock based compensation to revenue	0	0	0	0	0
Graham number	137.92	48.66	121.01	131.88	205.49
ROIC	0.06	-0.07	0.08	0.07	0.13
Return on tangible assets	0.06	0.01	-0.08	0.07	0.13
Graham Net	-88.86	-95.11	-74.17	-88.44	-75.23
Working capital	2.67B	2.18B	1.71B	1.3B	2.13B
Tangible asset value	2.59B	2.51B	1.9B	3.37B	5.14B
Net current asset value	-4.8B	-5.41B	-5.01B	-4.37B	-2.99B
Invested capital	0.36	0.47	0.49	0.38	0.28
Average receivables	0	0	0	0	0
Average payables	1.38B	1.36B	1.24B	1.66B	2.21B
Average inventory	1.59B	1.64B	1.41B	1.49B	1.93B
Days sales outstanding	0	0	0	0	0
Days payables outstanding	63.56	56.54	60.62	91.42	69.59
Days of inventory on hand	74.42	70.26	62.85	74.86	63.93
Receivables turnover	0	0	0	0	0
Payables turnover	5.74	6.46	6.02	3.99	5.24
Inventory turnover	4.9	5.19	5.81	4.88	5.71
ROE	0.08	0.01	-0.13	0.11	0.18
Capex per share	-8.07	-8.3	-5.19	-6.14	-8.76

Quarterly Fundamentals Overview

Last date of statement is 2022-12-31 for Q4

Metric	2021-12-31	2022-03-31	2022-06-30	2022-09-30	2022-12-31
Revenue per share	31.61	35.61	39.17	42.5	37.65
Net income per share	3.53	3.25	6.8	4.35	3.97
Operating cash flow per share	3.98	3.68	4.57	4.87	6.22
Free cash flow per share	1.14	2.5	3.07	2.91	2.1
Cash per share	11.28	13.26	14.19	13.07	10.97
Book value per share	84.26	91.44	100.83	108.56	102.19
Tangible book value per share	32.48	39.53	46.58	52.62	49.58
Share holders equity per share	84.26	91.44	100.83	108.56	102.19
Interest debt per share	32.4	34.22	36.46	33.01	28.82
Market cap	10.6B	9.28B	8.02B	8.26B	9.8B
Enterprise value	13.01B	11.76B	10.64B	10.71B	11.83B
P/E ratio	7.24	6.88	2.84	4.58	5.95
Price to sales ratio	3.23	2.51	1.97	1.87	2.51
POCF ratio	25.66	24.29	16.92	16.36	15.2
PFCF ratio	89.83	35.82	25.22	27.36	44.96
P/B Ratio	1.21	0.98	0.77	0.73	0.92
PTB ratio	1.21	0.98	0.77	0.73	0.92
EV to sales	3.97	3.18	2.62	2.43	3.03
Enterprise value over EBITDA	23.56	17.53	9.57	13.39	20.22
EV to operating cash flow	31.5	30.79	22.46	21.22	18.34
EV to free cash flow	110.23	45.41	33.47	35.48	54.26
Earnings yield	0.03	0.04	0.09	0.05	0.04
Free cash flow yield	0.01	0.03	0.04	0.04	0.02
Debt to equity	1.28	1.29	1.21	1.14	0.94
Debt to assets	0.56	0.56	0.55	0.53	0.48
Net debt to EBITDA	4.36	3.7	2.36	3.06	3.47
Current ratio	1.24	1.29	1.27	1.33	1.44
Interest coverage	26.09	13.88	29.19	21.17	14.17
Income quality	1.13	1.13	0.67	1.11	1.55
Dividend Yield	0	0.02	0.03	0	0
Payout ratio	0	0.46	0.35	0	0
Sales general and administrative to revenue	0.08	0.07	0.07	0.06	0.08
Research and developement to revenue	0.03	0.02	0.02	0.02	0.02
Intangibles to total assets	0.27	0.25	0.25	0.24	0.27
Capex to operating cash flow	-0.71	-0.32	-0.33	-0.4	-0.66
Capex to revenue	-0.09	-0.03	-0.04	-0.05	-0.11
Capex to depreciation	-1.7	-0.55	-0.69	-0.82	-1.91
Stock based compensation to revenue	0	0	0	0	0
Graham number	81.79	81.76	124.19	103.04	95.55
ROIC	0.02	0.02	0.04	0.03	0.03
Return on tangible assets	0.03	0.02	0.04	0.02	0.03
Graham Net	-88.28	-95.22	-97.56	-81.68	-60.57
Working capital	1.3B	1.94B	1.94B	2.36B	2.13B
Tangible asset value	3.37B	4.1B	4.83B	5.46B	5.14B
Net current asset value	-4.37B	-3.74B	-3.65B	-3.36B	-2.99B
Invested capital	0.38	0.37	0.36	0.3	0.28
Average receivables	0	0	0	1.22B	2.23B
Average payables	1.92B	2.22B	2.36B	2.54B	2.48B
Average inventory	1.67B	1.87B	2.07B	2.26B	2.24B
Days sales outstanding	0	0	0	49.61	46.67
Days payables outstanding	74.28	73.86	72.68	72.55	70.02
Days of inventory on hand	60.82	64.26	64.41	64.9	64.32
Receivables turnover	0	0	0	1.81	1.93
Payables turnover	1.21	1.22	1.24	1.24	1.29
Inventory turnover	1.48	1.4	1.4	1.39	1.4
ROE	0.04	0.04	0.07	0.04	0.04
Capex per share	-2.84	-1.19	-1.5	-1.96	-4.12

SOLB.BR Dividend History

SOLB.BR Frequently Asked Questions

What is Solvay SA stock symbol ?

Solvay SA is a BE stock and trading under the symbol SOLB.BR

What is Solvay SA stock quote today ?

Solvay SA stock price is $98.62 today.

Is Solvay SA stock public?

Yes, Solvay SA is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 210.11K
Market Capitalization 10.28B
Employee 21K
CEO Dr. Ilham Kadri
Headquarters Brussels,BE
IPO Date 2012-01-23
Website https://www.solvay.com

Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aircraft, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, specialty phenols, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the flavors and fragrances industries, as well as synthetic intermediates used in pharmaceuticals, agrochemicals, and electronics. This segment also provides friction reducers, gelling agents, emulsion breakers, surfactants, inhibitors, cementing additives, and biocides for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.